oligodendrocyte

December 12, 2017December 14, 2017

Protamine, Anticoagulant Blocker, Seen to Aid Remyelination in Mice Within Limits

News

Protamine — an agent used to stop the anticoagulant effects of heparin — was seen to trigger remyelination in mice with myelin damage. But while pointing a ... Read more

March 16, 2017March 16, 2017

Discovery of T-cells’ Role in Myelin Regeneration Could Lead to Therapies That Mimic Processes

News

Regulatory T-cells in the central nervous system trigger the maturation of stem cells that increase the production of myelin at injured neurons — a discovery that ... Read more

January 23, 2017January 23, 2017

Astrocytes Can Turn Aggressive and Kill Neurons, Potentially Groundbreaking Study Says

News

In what may be one of the most significant discoveries in neurodegenerative disease, researchers have found that brain cells, called astrocytes, contribute to killing neurons and myelin-forming ... Read more

December 12, 2016December 12, 2016

Discovery of Calcium Channel Crucial to Myelin Formation May Provide New MS-treatment Leads

News

A specific type of channel that facilitates calcium flow is needed for normal development of cells that produce a shield, called myelin, around nerve fibers — ... Read more

June 22, 2016July 26, 2016

Unexpected Diversity of Crucial Brain Cells Discovered in MS Mouse Study

Columns, What's Important Now -- An MS Column by Ian Franks

Discovery of an unexpected diversity of oligodendrocytes in mice could lead to new insights into mechanisms of degeneration and regeneration in multiple sclerosis and other diseases ... Read more

June 17, 2016June 17, 2016

Myelin-Producing Brain Cells Seen for 1st Time to Be Highly Diverse and Specialized

News

Oligodendrocytes — brain cells that wrap themselves around neurons to produce myelin — are much more diverse than previously believed. Scientists in Sweden, using a new type of ... Read more

February 18, 2016February 19, 2016

Anavex Life Sciences to Present Preclinical Data on Lead MS Drug Candidate at ACTRIMS 2016

News

Anavex Life Sciences Corp., a biopharmaceutical company focused on the development of new therapies for neurodegenerative and central nervous system (CNS) diseases, among others, recently announced ... Read more

December 22, 2015December 22, 2015

Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial

News

GeNeuro SA, a company developing therapies for neurological and autoimmune disorders, recently announced the initiation of a Phase 2b clinical trial to assess its lead investigational ... Read more

Pin It on Pinterest